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SUMMARY

Alternative translation initiation and stop codon
readthrough in a few well-studied cases have been
shown to allow the same transcript to generate multiple protein variants. Because the brain shows a
particularly abundant use of alternative splicing, we
sought to study alternative translation in CNS cells.
We show that alternative translation is widespread
and regulated across brain transcripts. In neural cultures, we identify alternative initiation on hundreds of
transcripts, confirm several N-terminal protein variants, and show the modulation of the phenomenon
by KCl stimulation. We also detect readthrough in
cultures and show differential levels of normal and
readthrough versions of AQP4 in gliotic diseases.
Finally, we couple translating ribosome affinity purification to ribosome footprinting (TRAP-RF) for celltype-specific analysis of neuronal and astrocytic
translational readthrough in the mouse brain. We
demonstrate that this unappreciated mechanism
generates numerous and diverse protein isoforms
in a cell-type-specific manner in the brain.
INTRODUCTION
‘‘One gene, one protein’’ has long been an obsolete axiom. Cells
use alternative splicing, where a single gene generates multiple
transcripts, each of which may be translated into a protein isoform (Graveley, 2001). To further expand proteomic landscapes,
cells can also utilize alternative translation initiation sites (TISs)
and termination sites on a given transcript (Dabrowski et al.,
2015; Kozak, 1999). Alternative splicing is well studied and
known to be modulated by neural activity and disease states
and in a cell-type-specific manner in the CNS (Hermey et al.,
2017; Licatalosi and Darnell, 2006; Parikshak et al., 2016; Quesnel-Vallières et al., 2016; Zhang et al., 2014b). However, alternative initiation and termination have not yet been systematically

surveyed across the CNS or assessed for variation across neurons and astrocytes. In other tissues, genomic and proteomic
studies have revealed a widespread use of alternative TISs (Slavoff et al., 2013; Ingolia et al., 2011; Vanderperre et al., 2013; Wan
and Qian, 2014; Zupanic et al., 2014; Menschaert et al., 2013;
Lee et al., 2012) and stop codon readthrough (Dunn et al.,
2013; Jungreis et al., 2011). In the CNS, only single-gene studies
have been done, which have identified alternative open reading
frames for individual transcripts and demonstrated their functional roles in homeostasis and disease (Bergeron et al., 2013;
Chua et al., 2012; De Bellis et al., 2017; Delmas et al., 1992;
Green et al., 2016; Simkin et al., 2008; Studtmann et al., 2014;
Thomas et al., 2008; Vanderperre et al., 2011).
With alternative initiation and termination, ‘‘one transcript,
one protein’’ also becomes an untrue axiom. In conventional
eukaryotic initiation, a 43S preinitiation complex scans the
50 UTR until it encounters an AUG at the annotated TIS (aTIS),
where the 60S ribosomal subunit joins it to form an 80S initiation
complex (Jackson et al., 2010). However, an 80S complex may
assemble at an upstream TIS (uTIS) if the 50 UTR has an optimal
AUG (or near-cognate NUG) or at a downstream TIS (dTIS) if the
aTIS is suboptimal (Kozak, 1999). Similarly, in conventional
termination, the 80S complex concludes translation at the first
in-frame stop codon. For some transcripts, however, it may
read past that stop codon at some frequency and conclude
translation at a second stop codon in the 30 UTR (Dabrowski
et al., 2015). As expected, alternative initiation may generate
N-terminal protein isoforms when in frame or entirely different
protein species when out of frame, whereas stop codon readthrough can give rise to C-terminally extended protein isoforms
(Figure 1A).
Here we profiled and examined the regulation of alternative
TISs and stop codon readthrough in CNS cells. We screened
for uTISs and dTISs genome-wide in neuron-glia cultures using
ribosome footprinting (RF), determined a subset of these protein
products in neurons using liquid chromatography-tandem mass
spectrometry (LC-MS/MS), and then examined how their use is
regulated by KCl depolarization. We also identified transcripts
evidencing stop codon readthrough in cultures and then focused
on one of the candidates, Aqp4, to determine whether the
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Figure 1. RF of Homoharringtonine-Treated Neuron-Glia Culture Reveals Translation Initiation Sites
(A) uTISs, aTISs, and dTISs and the corresponding protein products are depicted. uTISs and dTISs give rise to N-terminal variants of the protein when in frame,
but code for completely new polypeptide sequences when out of frame. Stop codon readthrough that generates a C-terminal extension is also depicted.
In this study, Figures 1, 2, and 3 concern TISs, and Figures 4, 5, and 6 concern readthrough.
(B) Experimental workflow for the in vitro study. Mixed neurons and glia from post-natal day (P)0 mice were cultured for 7 days in vitro, exposed to KCl or no KCl,
and subjected to RF and TIS-mapping RF as shown.
(C) Average ribosomal density across transcripts shows a run-off of elongating ribosomes from the proximal 300-nt region of the coding sequence in the HHTtreated sample as compared to the no-HHT sample. Plot from the KCl-untreated cultures is shown; KCl-treated cultures gave the same density distributions.
(D) The number of high-fidelity TISs in the 426 most robustly expressed transcripts. Most of the transcripts showed >1 TIS. Only the top-five TISs were called.
(E) Codon composition and frame status of TISs across transcripts. TIS codons are shown as ATG or a cognate thereof (NTG). Numbers inside the bars indicate
the percentages of in-frame TISs.
RF, ribosome footprinting; HHT, homoharringtonine; TIS, translation initiation site; u/a/dTIS, upstream/annotated/downstream TIS. Also see Figures S1 and S2
and Table S1.

resulting extended protein is regulated by diseases. Finally, we
coupled translating ribosome affinity purification to RF (TRAPRF) to determine the extent to which neurons and astrocytes
use readthrough in vivo.
RESULTS
RF of Homoharringtonine-Treated Neuron-Glia Cultures
Reveals Use of Novel TISs In Vitro
To investigate alternative TISs, we used mouse brain-derived primary neuron-glia mixed cultures as our experimental platform

because they offer two advantages. First, such cultures can be
rapidly and synchronously treated with homoharringtonine (HHT)
to arrest initiating ribosomes while allowing elongating ribosomes
to run off the transcript (Ingolia et al., 2011). Non-neural cell cultures treated successively with HHT and cycloheximide (CHX), a
drug that immobilizes elongating ribosomes (Schneider-Poetsch
et al., 2010), have been used to identify TISs previously (Ingolia
et al., 2011). Second, KCl treatment of neuronal cultures induces
membrane depolarization, inflow of Ca2+ through L-type Ca2+
channels, and expression of c-Fos and other activity-dependent
genes, thus offering a simple yet effective paradigm for studying

Cell Reports 26, 594–607, January 15, 2019 595

Table 1. Peptide Products of Alternative Translation Initiation
Sites Detected by Mass Spectrometry Analysis of Neuronal
Cultures
Transcript ID

Gene
Symbol

Alternative
Initiation Site

Frame

ENSMUST00000031131

Uchl1

+15

in frame

ENSMUST00000031565

Fascn1

+12

in frame

ENSMUST00000106255

Cap1

+9

in frame

ENSMUST00000028981

Mapre1

+12

in frame

ENSMUST00000112229

Gpm6b

+12

in frame

ENSMUST00000174548

Hnrnpl

+102

in frame

ENSMUST00000007980

Hnrnpa0

54

in frame

ENSMUST00000067664

Ywhae

66

in frame

ENSMUST00000143971

Minos1

21

in frame

ENSMUST00000021497

Rtn1

63

in frame

+ and  indicate downstream and upstream relative to the canonical initiation site, respectively. Also see Table S2.

activity-dependent gene regulation (Bading et al., 1993; Kim et al.,
2010; Greer and Greenberg, 2008).
Accordingly, we utilized neuron-glia cultures with or without
HHT and KCl treatments and subjected them to RF following
CHX treatment (Figure 1B). We first ensured our data had the
characteristics of bona fide ribosome footprints—specifically,
we confirmed that ribosomal P sites primarily correspond to
the correct reading frame and display the characteristic 3-nt
periodicity in the coding sequence (CDS) when compared to
the UTRs (Figure S1). Next, we examined footprint distribution
with HHT treatment, which revealed a near-complete run-off of
ribosomes from the proximal 300-nt region of the CDS 2 min after
introducing the drug (Figure 1C). We focused on this 300-nt region of the most robustly expressed transcripts and developed
a set of stringent criteria (see STAR Methods) to detect high-fidelity TISs in both KCl-treated and -untreated cultures. We detected TISs in 426 transcripts, most of which possessed multiple
TISs, with 89.7% having two or more and only 11.3% possessing
a single one (Table S1; Figure 1D). Although previous highthroughput studies on TISs have used non-neural cells, we
compared our list of alternative TISs to published lists generated
from mouse embryonic stem cells (Ingolia et al., 2011) or various
human cultured cells (Vanderperre et al., 2013) and found that
more than 50% of the transcripts in our list overlapped with the
lists from the previous studies. These results convinced us that
RF on HHT-treated neuron-glia culture combined with a stringent analysis is able to detect alternative TISs in neural
transcripts.
Because the number, composition, and frame of TISs are
important determinants of the proteomic complexity of a cell,
we examined these features across the transcripts for which
we detected high-fidelity TISs (Figure 1E). On average, a transcript contained 3.18 TISs—with 1.33 uTISs, 0.94 dTIS, and
0.91 aTIS. The aTIS-per-transcript value of <1 resulted from
the absence of an initiation peak at the annotated ATG of
some transcripts, suggesting that these transcripts might be
misannotated or the dominant protein isoform is not the canon-
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ical one in neural cells. ATGs detected at aTISs were always in
frame, consistent with their presence as a key contributor to
the original annotation. Similarly, near-cognate codons such as
CTG, TTG, and GTG detected at aTISs were in frame >99% of
the time. On the other hand, ATGs and cognate codons detected
at uTISs and dTISs were out of frame R47% of the time. These
data suggest that a brain transcript may use multiple TISs, each
at a rate that is regulated in a transcript-specific manner, which
can generate multiple protein variants or completely different
peptide sequences.
LC-MS Detects Protein Products of Alternative Initiation
We next asked whether a subset of the alternative TISs results in
a detectable amount of polypeptides, and were interested to
identify which of these were specifically coming from neurons.
We noted that most uTISs and dTISs are close to their corresponding aTISs, suggesting that a biochemical assay such as
a western blot would not clearly resolve the alternative and
normal protein isoforms. Therefore, we examined a quantitative
proteome of cultured primary mouse cortical neurons using LCMS. In spite of the different sensitivities of LC-MS and RF, we
clearly detected variant N-terminal peptides resulting from 10
of the predicted alternative TISs (Table 1). These included a peptide from an in-frame uTIS lying at the 63rd nt of Rtn1, which encodes reticulon 1, an endoplasmic reticulum protein expressed
in neuroendocrine cells and potentially involved in vesicle secretion (Chiurchiù et al., 2014), and a peptide from an in-frame dTIS
at the 15th nt of Uchl1, which encodes ubiquitin C-terminal hydrolase L1, a neuron-specific deubiquitinating protease with
protective roles in neurodegeneration and Alzheimer’s disease
(Bilguvar et al., 2013; Zhang et al., 2014a) (Figures 2A and 2B).
We also examined the proteome of the mouse brain reported
by others (Sharma et al., 2015) and found variant N-terminal peptides corresponding to 18 alternative TISs—5 as confirmed by
neuronal LC-MS, and 13 additional (Table S2). Thus, at least a
subset of the TISs detected by our algorithm is utilized in the
CNS to produce detectable protein, and alternative translation
does contribute to the diversity in the brain proteome.
To determine whether the identified alternative TISs might
represent evolutionarily important adaptations, we examined
their conservation across phyla. We used PhastCons (Siepel
et al., 2005) in a multi-species alignment of 60 vertebrates to
compute conservation scores for the NTGs (ATG, CTG, GTG,
or TTG) detected as alternative TISs, and tested the hypothesis
that these were more conserved than their background
sequence (the entire 50 UTRs for uTISs and the entire CDSs for
dTISs). We also computed the score for the NTGs not detected
as alternative TISs and the respective 50 UTRs or CDSs. Surprisingly, regardless of alternative TISs or not and in frame or not,
50 UTR NTGs were less conserved whereas CDS NTGs were
generally more conserved than their respective backgrounds
(Figures 2C and 2D). However, NTGs detected both as uTISs
or dTISs were not more conserved than NTGs detected in their
respective backgrounds. When we specifically examined the
conservation of the ten alternative TISs for which we detected
the corresponding peptides with LC-MS (Table 1), we found
eight of them to be highly conserved, one only moderately
conserved, and one not conserved (Figure 2E). In sum, our

Figure 2. Mass Spectrometry Detects the Peptides Resulting from Alternative TISs
(A and B) Peptides resulting from an in-frame uTIS (Rtn1) (A) and an in-frame dTIS (Uchl1) (B). Upper: the percentage of ribosomes at different TISs (red
arrowheads correspond to alternative TISs whose novel products are detected; zeros correspond to aTISs). Middle: the peptide sequences with the amino acids
corresponding to alternative TISs and aTISs in red and green, respectively. Bottom: the tandem mass spectra and mass-to-charge ratios of b and y product ions
confirming peptide sequences. Alternative TISs for Rtn1 and Uchl1 lie at the 63rd and +15th nt relative to the aTIS, respectively.
(C and D) Conservation of uTISs with respect to 50 UTR (C) and of dTISs with respect to CDS (D). Violin plots show the average of the PhastCons scores for the 3 nt
of the ATG, CTG, GTG, or TTG present at the uTISs or dTISs or elsewhere in the 50 UTR or CDS. Wilcoxon test was used to assess the statistical significance.
(E) Conservation of the uTISs and dTISs of mass spectrometry-confirmed peptide products. Plot shows the average of the PhastCons scores of the 3 nucleotides.
Also see Tables S1 and S2.

analyses suggest that specific alternative TISs, particularly those
that are robust enough to generate detectable protein, may be
highly conserved. Yet, the significantly decreased conservation
of NTGs in 50 UTRs, even for the many that show initiation,
also suggests that some modifications of TISs may be a substrate for evolution of gene regulation across species.
TISs Reveal the Complexity of Initiation on Neural
Transcripts
We wanted to examine whether the identified TISs provide support for the well-accepted scanning model of initiation, which
postulates that the small ribosomal subunit scans the 50 UTR
of a transcript and triggers initiation at an AUG, or near cognate,
surrounded by specific nucleotides (Kozak sequence) (Kozak,
1999). To this end, we quantified the Kozak strength of each
TIS by using the Kozak consensus sequence empirically
derived from a synthetic translation assay as a benchmark
(Sample et al., 2018) and the relative usage of each TIS by
dividing the ribosomal occupancy at that TIS over the total ribosomal occupancy across all TISs on a given transcript. Overall,
aTISs possessed significantly stronger Kozak sequences than
uTISs and dTISs (Figure S2A). Comparing the two quantities

across all TISs in all transcripts, we found that TISs with stronger Kozak scores—especially aTISs, as expected—are generally used more frequently than those with weaker Kozak scores
(Figure S2B). Next, comparing uTIS Kozak scores with aTIS
usage, we observed that uTISs with stronger Kozak scores
are strongly suppressive toward aTISs (Figure S2C), consistent
with the idea that they can act as a sink for the scanning
ribosomal subunits that would otherwise proceed downstream
(Kozak, 1999). Finally, we found that 50 UTRs possess more
uTISs as a function of their length (Figure S2D), and consequently longer 50 UTRs are more suppressive toward aTISs
than shorter 50 UTRs (Figure S2E). Based on a multivariate
analysis, the aTIS Kozak score and uTIS Kozak score are the
best predictors of aTIS usage (R-squared 0.518985) (Figure S2F). These results reveal an interplay between uTISs and
aTISs that is likely to regulate the amount of canonical proteins
synthesized from neural transcripts.
Similarly, we found that aTISs with stronger Kozak scores
exert suppression toward dTISs; however, this effect was
more modest (Figure S2G), suggesting additional factors might
regulate dTIS usage. Codon bias is known to influence local ribosomal traffic (Tuller et al., 2010), and therefore post-aTIS
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codon bias can arguably affect the access of ribosomes to
dTISs (e.g., an inefficiently translating ribosome downstream
of the first aTIS might block access to subsequent dTISs by
scanning ribosomes). When we compared the post-aTIS and
post-dTIS regions for codon composition, we indeed found
specific codons and amino acids to be significantly different between the two (not shown). However, aside from the expected
increase in ATGs at aTISs relative to dTISs, the remaining observations (depleted AGG and CAC) did not clearly match any
expectations from codon usage biases. Although these observations do not rule out the possibility of additional mechanisms
that might regulate dTIS usage, they show that the codons
immediately beyond an aTIS may be skewed more than expected by chance and potentially regulate ribosomal encounter
with a dTIS.
Transcripts Change TIS Usage in Response to Neuronal
Depolarization
Neuronal activity induces de novo protein synthesis—both
from existing mRNAs and via induction of a specific transcriptional program (Costa-Mattioli et al., 2009; Dalal et al., 2017;
Flavell and Greenberg, 2008). However, it is unclear whether
it can also alter TIS usage on a given transcript. Therefore,
we asked whether KCl depolarization of our neuron-glia culture
model regulates the use of TISs. For this purpose, we removed
transcripts that had only one TIS and/or no aTIS from our list of
transcripts. We found that, of the remaining transcripts with
at least one alternative TIS, 32.5% exhibited a significant
change in the ribosomal occupancies of their aTISs, uTISs,
or dTISs, with a majority showing increased use of aTISs in
response to KCl depolarization (Figure 3A). More importantly,
we observed that an increased use of aTISs was accompanied
by a corresponding decreased use of alternative TISs and vice
versa, with a few exceptions where changes at both TISs went
in the same direction. These results indicate that specific transcripts use their TISs differentially in response to neuronal
depolarization.
We then examined the transcripts exhibiting depolarizationregulated use of TISs. The increased use of aTISs by the majority of transcripts was consistent with an increase in de novo protein synthesis from the canonical open reading frame following
stimulation. Transcripts that showed this included Grina and
Hspa4, which code for an NMDA receptor subunit and a heat
shock protein involved in the folding of other proteins, respectively (Garcia-Quintanilla and Miranzo-Navarro, 2016; Stetler
et al., 2010) (Figures 3B and 3C). On the other hand, among
the few transcripts that showed an increased use of uTISs
was Kif1b, which codes for a kinesin superfamily protein
involved in transporting synaptic vesicles (Hirokawa and Takemura, 2005) (Figures 3B and 3C). Interestingly, Gfap, which codes for an intermediate filament in astrocytes (Middeldorp and
Hol, 2011), also exhibited a modest regulation of its uTIS.
Notably, as shown in Figure 3A, we found that although some
of the uTISs and dTISs with altered usage were in frame, most
were out of frame, suggesting the regulated production of not
only N-terminal protein variants but also novel polypeptides
following activity. Overall, these findings show that stimulation
alters the use of TISs of several transcripts that are involved in
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diverse functions, indicating a regulated production of alternative protein isoforms in neural cells.
RF Identifies Novel C-Terminal Extensions Mediated by
Stop Codon Readthrough In Vitro
As illustrated in Figure 1A, stop codon readthrough is another
mode of alternative translation, and it generates a C-terminally
extended protein variant. Recently, RF was utilized to identify
readthrough in Drosophila embryos (Dunn et al., 2013). Shortly
thereafter, bioinformatics approaches predicted at least 7 readthrough events in human transcripts, of which 4 were validated
as capable of >1% readthrough using luciferase assays in HeLa
cells (Loughran et al., 2014). These included the Aqp4 transcript, which encodes a water channel that is highly expressed
in astroglia. A genome-wide screen for transcripts exhibiting
readthrough, however, has not yet been conducted in CNS
cells.
To profile readthrough in our neuron-glia cultures, we used the
RF dataset from HHT-untreated cultures and counted the footprints mapping to the 30 UTR of robustly expressed transcripts.
We carefully excluded any transcripts where alternative splicing
or stop codon SNPs might give rise to such footprints (see STAR
Methods for details). Overall, we identified 18 transcripts with at
least 1% readthrough (Table S3). These include Aqp4, as well as
malate dehydrogenase 1 (Mdh1) (Figure 4A). For an independent
validation of these findings, we cloned a cassette encompassing
the distal CDS and the readthrough region of candidate transcripts into a dual-luciferase vector so that Renilla luciferase
was constitutively expressed whereas firefly luciferase was
expressed only if the stop codon was read through (Fixsen and
Howard, 2010) (Figure 4B). Comparison of the relative luciferase
activities confirmed that the mouse Aqp4 sequence permits
readthrough of 12.5% when compared to a positive control
sequence where the stop codon was mutated to a sense codon
(Figure 4C). This is a level similar to that previously reported for
human AQP4 in HeLa cells (Loughran et al., 2014). Likewise,
the Mdh1 sequence permits readthrough at 5.5%, whereas the
Map2 sequence is not read through. The addition of an extra
stop codon beyond the original stop codons abrogated the readthrough of both Aqp4 and Mdh1, indicating luciferase expression
is not due to a cryptic promoter or internal ribosome entry site
sequence.
For another independent validation of readthrough, we
analyzed our neuronal LC-MS data but were unable to detect
any extended peptides (see Discussion). We then resorted to
mouse brain MS data from others (Sharma et al., 2015), and
could detect readthrough peptides for Aqp4, Ttr (transthyretin), and Map1lc3a (microtubule-associated protein 1 light
chain 3 alpha) (Figure S3). We noticed that whereas readthrough of the latter two transcripts was not detected by our
neuron-glia RF, that of several others that are strongly expressed in the brain and well known to undergo readthrough,
including MDH1 (Hofhuis et al., 2016), was not detected by
MS, suggesting MS negative results should be interpreted
with caution. Interestingly, an arginine was incorporated in
lieu of the TGA stop codon of Aqp4, suggesting that other
amino acids besides those predicted by tRNA wobbling such
as tryptophan (TGG) or a cysteine (TGT, TGC) can be

Figure 3. Neuronal Activity Modulates the Use of TISs
(A) Heatmap shows transcripts with significant changes (false discovery rate %0.05) in the usage of aTISs, uTISs, or dTISs in response to KCl depolarization of
neuron-glia culture. Usage of a TIS was computed as the P site counts at that TIS divided by the total P site counts across all TISs for a given transcript. For transcripts
with multiple uTISs and dTISs, combined changes over all uTISs and dTISs is shown. Chi-square was used to test for the difference of P site counts across TISs.
(B) Representative tracts are shown to highlight the abundance of ribosomes at TISs and the use of different TISs in response to KCl depolarization. Numbers on
the x axis indicate nucleotide positions, with zero being the aTIS, and numbers on the y axis indicate the percentages of ribosomes. Arrowheads point to the uTISs
and dTISs.
(C) Boxplot quantifies the KCl-mediated shifts in TIS use of the transcripts shown in (B). n = 3, paired t test. Error bar, SEM.
Also see Table S1.

incorporated, and similar to what has previously been seen by
Hofhuis et al. for Mdh1. Together, our results show the possibility of several readthrough events in the brain, highlight the

conflict between RF and MS in detecting readthrough, and
provide a case of how the stop codon might be recoded in
readthrough.
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Figure 4. RF of Cycloheximide-Treated Neuron-Glia Culture Reveals
Stop Codon Readthrough In Vitro
(A) A schematic of footprint mapping and genome browser tracts with examples of readthrough are shown. Aqp4 and Mdh1 display footprints mapping to
the readthrough region, whereas Map2 does not.
(B) Dual-luciferase assay assessing the permissiveness of sequences for
readthrough. A cassette spanning the distal CDS and the readthrough region is
cloned between the Renilla luciferase (RL) and firefly luciferase (FL) such that
the latter is expressed in transfected cells only if ribosomes read past the
cassette. The stop codon is mutated to a sense codon in the positive control,
whereas an extra stop codon is added in the negative control.
(C) Dual-luciferase assay shows that Aqp4 and Mdh1 undergo readthrough at
the rates of 12.5% and 5.5%, respectively, and that Map2 does not undergo
readthrough. Readthrough rate is calculated as shown in (B) (n = 3; error bar,
SEM).
CDS, coding sequence; RA, Renilla activity; FA, firefly activity; Ct, control. Also
see Table S3 and Figure S3.

Readthrough Localizes AQP4 to the Perivascular Region
in the CNS
We next wanted to test whether readthrough is of functional significance. We focused on AQP4, an astrocyte membrane protein
shown to have a readthrough version in other species by previous
studies (De Bellis et al., 2017; Loughran et al., 2014). To detect
readthrough-extended AQP4 (designated AQP4X hereafter), we
developed a rabbit polyclonal antibody using a peptide from the
readthrough region as an epitope. The antibody recognized
AQP4X but not AQP4 in immunofluorescence staining of cell cultures expressing the respective version of AQP4, thus demonstrating sensitivity and specificity (Figure S4). Western blot on
mouse brain lysates revealed that anti-AQP4X recognizes the expected 35-kDa band in the adult brain but not in the developing
brains of postnatal day 9 or younger mice (Figure S5A). This is
interesting because astrocyte maturation, particularly the endfeet
at the blood-brain barrier, are not complete until 3 weeks of age
(Caley and Maxwell, 1970). In line with western blot, immunofluorescence staining showed that AQP4X is abundant in the adult
mouse brain (Figure S5B). We noted that AQP4X is significantly
concentrated perivascularly and adjacent to the endothelial cell
marker PECAM-1, whereas AQP4 is also abundant farther from
the blood vessels (Figures S5B and S5C). Similar results were
also recently reported by others with an independently raised
antibody in rats (De Bellis et al., 2017). Thus, readthrough confers
a conserved perivascular localization signal to AQP4.
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Because commercial anti-AQP4 antibodies also recognize
AQP4X, our immunofluorescence data above could not resolve
whether AQP4 also is perivascular to some extent. To address
this, we transduced mouse brains with adeno-associated virus
9 (AAV9) expressing cMyc-Aqp4X (Aqp4 mRNA with an additional stop codon to prevent readthrough) or cMyc-Aqp4X+
(Aqp4 stop codon mutated to allow 100% readthrough) under
the astrocytic promotor Gfap and examined cMyc epitope
expression from the two viruses using immunofluorescence staining (Figure S5D). Although virally expressed proteins showed
slightly unusual subcellular expression patterns (compare Figures
S5B and S5D), possibly due to overexpression relative to binding
partners, AAV9-Gfap::cMycAqp4X still clearly resulted in significantly less perivascular cMyc than AAV9-Gfap::cMycAqp4X+
(Figure S5E). These results are consistent with the above data
on endogenous AQP4 and AQP4X, and suggest that AQP4X is
relatively enriched in the perivascular region.
AQP4 is expressed in numerous tissues and required
for their normal functioning (Mobasheri et al., 2007; Nagelhus
and Ottersen, 2013). Therefore, we also asked whether its
readthrough is a brain-specific or a ubiquitous phenomenon.
By immunofluorescence staining, we detected AQP4X in the
retina as well as the kidneys (Figures S5F and S5G). However,
whereas AQP4X was mostly perivascular, and hence distinct
from AQP4 in the retina, it was completely overlapping with
AQP4 in the kidneys. Thus, AQP4 readthrough is not a brainspecific phenomenon; however, whether it alters subcellular
localization depends on the tissue.
AQP4 and AQP4X Are Differentially Regulated by Gliosis
across Multiple Disease Models
Currently, it is unclear whether readthrough always occurs at a
consistent rate or is regulated in response to conditions in the
brain. The AQP4 gene has been implicated in diverse (patho)
physiological conditions in the brain, including brain water
homeostasis, edema, and ischemia (reviewed in Nagelhus and
Ottersen, 2013). Given the largely mutually exclusive localizations of AQP4 and AQP4X in the brain, we first examined whether
they are independently regulated in ischemia. We induced
ischemia in adult mice by transient middle cerebral artery occlusion (tMCAO). In mice, MCAO results in relatively reproducible
infarcts in the lateral caudatoputamen and frontoparietal cortex
(Sicard and Fisher, 2009). We performed immunostaining for
AQP4 and AQP4X in ischemic mouse brains and quantified their
signals in gliotic peri-infarct regions. We found that compared to
the regions in the contralesional hemisphere, GFAP-labeled periinfarct regions showed a 2.5-fold upregulation of AQP4 but only
a disproportionate 1.3-fold upregulation of AQP4X (Figures 5A
and 5B). This difference suggested that AQP4X generation,
degradation, post-translational modification, or folding can be
differentially regulated during pathological processes.
To determine whether this regulation was driven by the
ischemia itself or was more parsimoniously explained as part
of gliosis, we used mice lacking palmitoyl protein thioesterase1 (PPT1), a lysosomal enzyme that is absent in human patients
with infantile Batten disease (Gupta et al., 2001). PPT1/ mice
exhibit several key features of this disease, including neurodegeneration and gliosis (Bible et al., 2004; Gupta et al., 2001).

Figure 5. AQP4 and AQP4X Are Differentially Upregulated in Gliosis
(A, C, and E) Immunostaining for AQP4, AQP4X, and GFAP in brain sections from mice with middle cerebral artery occlusion (A), infantile Batten disease (C), and
injury-induced gliosis (E). Normal and gliotic hemispheres of the same sections are imaged in (A) and (E), and age-matched wild-type littermate controls are used
in (C).
(B, D, and F) Fluorescence intensities in (A), (C), and (E) quantified in (B), (D), and (F), respectively, show that AQP4 is significantly more upregulated than AQP4X by
gliosis. Regions of interest were drawn to cover the gliotic area and the contralateral normal area in (A), whereas whole images were considered in (B) and (C). 3
mice, 6 sections/mouse, paired t test; error bar, SEM.
(G) Barplot compiles the relative upregulations of AQP4 and AQP4X from (B), (D), and (F).
Scale bars, 20 mm. Also see Figures S4 and S5.

We compared the expression levels of AQP4 and AQP4X in
PPT1/ and wild-type brains using immunofluorescence staining and observed that they were indeed differentially regulated in

response to gliosis in the knockout brains. Whereas AQP4
expression was 2.5-fold upregulated, AQP4X was 1.5-fold upregulated (Figures 5C and 5D).
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Figure 6. TRAP-RF Detects Cell-Type-Specific Stop Codon Readthrough In Vivo
(A) TRAP-RF workflow. mRNAs from transgenic
brains expressing GFP-tagged ribosomes in
neurons (Snap25::Rpl10a-Egfp) or astrocytes
(Aldh1l1::Rpl10a-Egfp) are affinity purified with
anti-GFP-conjugated magnetic beads, and subjected to on-bead digestion with RNase and the
subsequent RF protocol as shown.
(B and C) Log2 (reads per kilobase million [RPKM])
of ribosome footprints mapping to the coding
sequence (B) and proximal 30 UTR (C) was reproducible between the replicate samples for both
Snap25::Rpl10a-Egfp and Aldh1l1::Rpl10a-Egfp.
(D) Comparison of TRAP-RF samples between
neurons and astrocytes shows the expected
enrichment of neuronal (green) and astrocytic (red)
transcripts identified in previous experiments
(Dougherty et al., 2012).
(E) Of the 50 transcripts detected undergoing R1%
readthrough in the brain, 21 are neuronal, 19 are
astrocytic, and the remaining 10 are non-cell-type
specific.
(F) Of the 18 transcripts with R1% readthrough in
neuron-glia culture, 13 do so in vivo as well.
IP, immunoprecipitation. Also see Table S4 and
Figures S3 and S6.

We also examined whether injury-induced gliosis also exerts a
similar regulatory effect on AQP4 and AQP4X, using tissue from
mice having undergone stereotactic injection, which can also
induce gliosis. We marked the site of injection using AAV9 expressing cMyc-tagged Cyan Fluorescent Protein (CFP) under
the Gfap promoter (Sakers et al., 2017). A robust expression of
cMyc and CFP (data not shown) and mild gliosis were evident
along the injected line after 1 month (Figure 5E). We then
repeated the immunostaining as above and found gliotic regions
to express AQP4 at 3-fold and AQP4X at 1.5-fold more
intensely as compared to the uninjected contralateral side (Figures 5E and 5F). Overall, our results indicate that diseases and
conditions accompanied by gliosis differentially regulate the
two isoforms of AQP4 (Figure 5G).
TRAP-RF Identifies Novel, Cell-Type-Specific,
C-Terminal Extensions Mediated by Stop Codon
Readthrough In Vivo
We finally sought to rule out the possibility that many alternate
translation events are due to the unnatural conditions of cell culture, and to determine whether the phenomenon is regulated in
a cell-type-specific manner. Therefore, we assessed alternative
translation in vivo, specifically focusing on readthrough, which,
unlike TISs, can be detected without pharmacological manipula-
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tion of the brain. Further, to analyze readthrough in a cell-type-specific manner,
we used mouse lines that express GFPtagged ribosomes in either neurons
(Snap25::Rpl10a-Egfp) or astrocytes
(Aldh1l1::Rpl10a-Egfp), thus allowing the
affinity purification of neuronal or astrocytic ribosome-bound mRNA (Dougherty et al., 2012; Doyle
et al., 2008). We subjected the transgenic brains to TRAP followed
by RF, an approach we call TRAP-RF (Figure 6A), similar to one
recently described by Gonzalez et al. (2014). The resulting footprints mapping to the transcriptome were highly reproducible between replicates (Figures 6B and 6C) and showed 3-nt periodicity
in the CDS (Figures S6A and S6B), indicating a good reliability of
the approach we have developed.
We confirmed enrichment of neuronal and astrocyte marker
genes in Snap25::Rpl10a-Egfp and Aldh1l1::Rpl10a-Egfp
TRAP-RF data, respectively, matching prior non-footprinted experiments using these lines (Dougherty et al., 2012; Doyle et al.,
2008), indicating we were indeed profiling ribosomes enriched
from the cell types of interest (Figure 6D). To be sure this
was not due to any TRAP-specific artifact, we also confirmed
robust enrichment of cell-type-specific markers derived from
neuron- and astrocyte-specific immune-panned transcriptomes
reported by Zhang et al. (2014b) (not shown). We went on and
applied the same stringent criteria as used for in vitro cultures
above to detect readthrough events and identified 50 transcripts
with at least 1% readthrough in the TRAP-RF data (Table S4),
and these were reproducible across replicates. To confirm these
were likely coding, we examined the codon bias of these regions.
Protein-coding regions show a conserved preference for

particular codons, and comparing the readthrough fragments to
an equivalent number of length-matched fragments from transcripts without readthrough revealed a significantly enriched
codon bias in the readthrough fragments (p < 0.002) that
matched the codon preferences of standard CDSs (not shown),
consistent with coding potential. Of the 50 transcripts, 21 were
neuron enriched, 19 were astrocyte enriched, and the remaining
10 were non-cell-type specific (Figure 6E). Comparing the in vitro
and in vivo results, we found that 13 out of the 18 in vitro candidates had clearly detectable readthrough in vivo (Figure 6F),
including Aqp4 and Mdh1.
Finally, we analyzed the 50 readthrough candidates to determine whether any cis-regulatory elements in the nearby sequence
mediate this phenomenon. Of the three standard stop codons, we
found TGA to be overrepresented in the readthrough candidates
(Figure S6C), consistent with prior studies (Jungreis et al., 2011).
Similarly, motifs for specific RNA-binding proteins were enriched
in readthrough regions as compared to shuffled sequence controls and readthrough-negative controls, suggesting these proteins might regulate specific aspects of readthrough candidates
(Figures S6D and S6E). In contrast to prior studies in other systems, however, we saw no bias for CUAG immediately downstream of the stop codon (Loughran et al., 2014). Further, we
found that readthrough regions were only moderately, but not
significantly, conserved as compared to the analog regions in
readthrough-negative transcripts (odds ratio 1.83, p = 0.19) (Figure S6F). Finally, we noticed that readthrough regions contain less
free energy than the analogous regions in readthrough-negative
transcripts (Figure S6G), suggesting the possibility that in addition
to the motifs for specific RNA-binding proteins, stable RNA
secondary structures might influence the phenomenon. Overall,
our TRAP-RF analysis identified both cell-type-specific and
shared readthrough candidates that possess specific sequence
features and possibly generate functionally important C-terminally extended protein variants in the brain.
DISCUSSION
Initially identified as viral strategies to diversify protein repertoire
(Sangar et al., 1987; Schwartz et al., 1992; Weiner and Weber,
1971), non-canonical translational events were later also reported in eukaryotes, including humans (Bazykin and Kochetov,
2011; Dunn et al., 2013; Ingolia et al., 2011; Jungreis et al., 2011;
Loughran et al., 2014). Now we present the first study showing
their extensive use in the brain. Specifically, we show that hundreds of neural transcripts use uTISs and dTISs in vitro, and
dozens undergo stop codon readthrough in specific cell types
of the brain in vivo. Our MS data demonstrate that several of
the uTISs and dTISs do give rise to measurable protein products
from neurons. Although MS did not identify any readthrough
peptides (more below), we ascertained the presence of AQP4X
in vivo using a readthrough-specific antibody. Thus, we establish
that non-canonical translation contributes to the heterogeneity
of the neural proteome.
We also provide two lines of evidence that the products of
non-canonical translation are likely to have functional significance in the brain but are not simply abnormal proteins destined
for immediate degradation. First, we found that they are regu-

lated: more than one hundred transcripts altered their preference
for different TISs in response to KCl stimulation. De novo protein
synthesis in the brain is required for not only housekeeping functions but also specialized functions such as long-term potentiation (Kandel, 2001). It is conceivable that the protein isoforms
induced by depolarization are involved in carrying out such brain
functions. Second, we found that readthrough localizes AQP4 to
astrocyte endfeet that enwrap the blood-brain barrier, and the
amounts of AQP4 and AQP4X are differentially altered in diverse
pathological conditions involving gliosis. These findings on
AQP4 and AQP4X might be of importance in the context of diseases such as stroke, in which cerebral edema is often a fatal
complication (Rosand and Schwamm, 2001), and infantile
Batten disease, in which the blood-brain barrier is disrupted
(Saha et al., 2012). Intriguingly, endfoot-polarized AQP4 is
required for the efficient removal of amyloid beta from the brain
(Iliff et al., 2012; Kress et al., 2014) and is lost in mouse models as
well as human patients with Alzheimer’s disease (Park et al.,
2014; Yang et al., 2011; Zeppenfeld et al., 2017), suggesting
that promoting AQP4X biosynthesis improves the disease
outcome. Identification of regulators of Aqp4 readthrough and
generation of AQP4X/ mice will allow the explicit testing of
the possible role of AQP4X in these diseases. Overall, we provide
compelling evidence that alternative protein isoforms have
implications in both normal brain functions and neurological
diseases.
Thus far, we have confirmed alternative isoforms for only a
subset of proteins by MS, although RF suggested the possibility
of hundreds of such isoforms. To some extent, this reflects the
fact that peptide-based measures are inherently more challenging and less sensitive than sequencing-based ones. For
instance, Menschaert et al. detected only 16 N-terminally
extended proteins in mouse embryonic stem cells using MS
(Menschaert et al., 2013), although Ingolia et al. had shown the
possibility of 570 of such proteins in the same cells using RF (Ingolia et al., 2011). Similarly, Sendoel et al. detected 13 peptides
corresponding to uTISs in transformed epidermal cells, although
they had identified 215 uTISs using RF (Sendoel et al., 2017).
Some of the alternative isoforms might exist in very small
amounts or be rapidly degraded after translation, further limiting
the ability of MS to detect them. In addition, our MS experiment
was conducted on a purer neuronal population cultured from a
younger age than the RF studies and hence was insensitive to
astrocyte-specific proteins such as AQP4. Another challenge is
that it is not entirely clear which amino acid would be included
in the peptide chain in lieu of the stop codon, and thus the
expected MS spectra of readthrough peptides are inherently
unpredictable. Indeed, the peptide found for Aqp4 had a
mass-to-charge ratio indicating it included arginine at the stop
position. It is also quite possible that many alternative TIS and
readthrough events do not produce stable proteins but serve
regulatory functions by engaging ribosomes. uTISs specifically
have been reported to serve regulatory functions in several transcripts (Calvo et al., 2009), often serving as decoys to suppress
the usage of the aTIS in a regulated manner. A prevalence of
such sequences would be consistent with the difficulty in detecting protein products, the relatively high frequency of movement
of ribosomes from uTISs to aTISs during stimulation, and
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potentially even significantly lower conservation of NTGs in UTR
sequences in general. Evolution across species is posited to be
driven more by changes in gene regulation (King and Wilson,
1975), typically interpreted with regard to enhancer usage
(Rubinstein and de Souza, 2013). The same logic may be true
at the level of regulation of translation initiation, and thus
evolution of new uTISs might serve to modulate protein levels
across species. Thus, negative results from the MS study should
be interpreted cautiously.
Our findings on TISs and readthrough highlight the several
potential mechanisms that may warrant future investigation.
We found that many alternative TISs are differentially used in
response to KCl, which is known to stimulate neurons by phosphorylating CREB protein via an influx of Ca2+ through L-type
Ca2+ channels (Macı́as et al., 2001). Previously, we have shown
that KCl stimulation of neural cultures modulates the ribosomal
occupancy of specific CDSs (Dalal et al., 2017). Others have
shown that KCl stimulation of neuronal cultures enhances TIS
by promoting the expression and activity of EIF4E (Moon
et al., 2009). What remains to be shown is how exactly the
KCl pathway influences the choice of a TIS by ribosomes. It is
intriguing to speculate whether it does so by regulating cis
elements like RNA secondary structures or phosphorylation
and regulation of trans factors such as RNA-binding proteins.
Likewise, we found that AQP4 readthrough is of functional
significance, and AQP4X level is differentially regulated by
gliosis. This, together with the conservation of several readthrough peptides in humans (De Bellis et al., 2017; Dunn
et al., 2013; Eswarappa et al., 2014; Stiebler et al., 2014), suggests that there are pathways that actively regulate the process.
Targeted manipulation of any such pathways may help define
the role of stop codon readthrough in the brain or other tissues.
Until then, targeting individual transcripts for deep analysis, as
was done for Aqp4 (De Bellis et al., 2017), may continue to
uncover novel roles for individual products arising from such
alternative translation events.
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Joseph
D. Dougherty (jdougherty@genetics.wustl.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
All procedures involving mice conformed to the Washington University institutional animal care and use committee. FVB
and C57BL/6J mice were purchased from the Jackson Laboratory. We have previously described Snap25::eGFP-RpL10a and
Aldh1l1::eGFP-RpL10a mice (Dougherty et al., 2012; Doyle et al., 2008), and others have described Ppt1/ mice (Gupta et al.,
2001). For immunostaining, tMCAO and viral transduction experiments, three mice (per test group where applicable) were used.
Except tMCAO, for which only male mice were used, all mouse experiments included both sexes. Mouse ages were embryonic
day {E} 16.5 (LC-MS); postnatal day {P} 0 (in vitro RF); P1 (viral experiment for perivascular proportions of Aqp4 and Aqp4X);
E17.5, P0, and P21 (Western blot); P21 (TRAP-RF, Aqp4X immunostaining); 14 weeks (tMCAO); 3 months (needle injury); and
6 months (immunostaining in Ppt1/).
Cell Lines and Primary Cultures
DBT glioblastoma cell line, derived from female mice, was used in dual-luciferase and antibody validation experiments has been previously reported (Kumanishi et al., 1973) and was obtained from Dr. Keith M. Rich’s laboratory at Washington University in St. Louis.
Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 5% fetal calf serum and 100 units/mL each of penicillin and
streptomycin and incubated at 37 C and in a humidified atmosphere with 5% CO2.
We have previously described the mouse primary neuron-glia cultures used for RF (Dalal et al., 2017) and primary neuronal cultures
used for LC-MS (Prabakaran et al., 2014).
METHOD DETAILS
Culture
Neuron-glia mix cultures from the cortices of full litters of P0 FVB mouse pups were generated as described (Dalal et al., 2017). After
7 days in vitro, cells were treated with 2 mg/ml HHT ((LKT lab) and compared to parallel cultures treated with DMSO (Dalal et al., 2017)
(Sigma) for 2 min, and then with 100ug/ml CHX (Sigma) for 7 min at 37 C before being lysed for RF (Ingolia et al., 2011). For examining
activity-induced TISs, cells were depolarized with 55mM KCl for 3 h (Bading et al., 1993; Kim et al., 2010) before HHT and CHX treatments. RF was conducted in duplicates.
RF
RF of cultured cells was performed as described (Dalal et al., 2017; Ingolia et al., 2011). Briefly, the cell lysates were treated with
RNaseI and subjected to sucrose-cushion ultracentrifugation for pelleting monosomes. mRNA fragments were isolated from the
monosomes, size-selected in a polyacrylamide, ligated to cloning linkers, and converted to cDNAs. The cDNAs were then circularized, depleted of rRNAs, PCRed and size-selected and finally deep-sequenced on Illumina Hiseq 2000 (50 bp, single end). Ribosomal
profiles of replicate cultures were highly reproducible, with Pearson’s r > 0.96.
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TRAP-RF
P21 Snap25::eGFP-RpL10a, Aldh1l1:: eGFP-RpL10a, along with their eGFP-negative littermates were euthanized, and their brains
frozen in liquid nitrogen and stored at 80 C until use. Two brains were pooled per sample, and replicate experiments were done.
TRAP was performed as described (Heiman et al., 2008) with a few modifications. Briefly, the brains were homogenized in ice in a
buffer (20 mM pH 7.4 HEPES, 150 mM KCl, 5 mM MgCl2, 0.5 mM dithiothreitol, 100 mg/ml CHX, Turbo DNase, protease inhibitors,
and RNase inhibitors). The lysates were cleared by centrifuging at 2000 xg for 10 min at 4 C and then treated with DHPC (to 30mM,
Avanti) and NP-40 (to 1%, Ipgal-ca630, Sigma) for 5 min in ice. Lysates were then further cleared by centrifuging at 20,000 xg for
15 min at 4 C and then mixed with protein L-coated magnetic beads (Invitrogen), previously conjugated with a mix of two monoclonal
anti-GFP antibodies (Doyle et al., 2008), and incubated with rotation for 4 h at 4 C. Beads were washed 5 times with a high-salt
buffer (20 mM pH7.4 HEPES, 350 mM KCl, 5 mM MgCl2, 1% NP-40, 0.5 mM dithiothreitol, and 100 mg/ml CHX) and then resuspended
in normal-salt buffer (150 mM KCl, otherwise as above). To couple to RF, on-bead RNA digestion was performed with RNase I
(Invitrogen) for 1 h with end-to-end rotation, followed by washing three times with normal-salt buffer. Small ribosomal subunits
with the mRNA fragments were eluted with ribosome dissociation buffer as described (20 mM pH7.3 Tris-HCl, 250 mM NaCl,
0.5% Triton X-100, 50mM EDTA) (Gonzalez et al., 2014). RNA was extracted with phenol-chloroform, quality-tested with Agilent
BioAnalyzer, and then subjected to dephosphorylation and subsequent library preparation as described for RF above.
Analysis of Sequence Data
Culture and TRAP-RF sequencing results were quality-tested using FastQC (version 0.11.2) (Simon, 2010), and one culture RF sample was removed due to low read depth. Trimmomatic (version 0.32) was used to trim low-quality bases from the ends of reads and to
remove adaptor sequences (Bolger et al., 2014). Only fragments 25-35 nt in length were retained for subsequent analysis. Reads
aligning to the mouse rRNA were removed using STAR (version 2.3.1z8) (Dobin et al., 2013). Surviving reads were then aligned, using
bowtie2(version 2.2.2) (Langmead and Salzberg, 2012), to the mouse transcriptome (downloaded from Ensembl Release 75) after
first removing degenerate sequences from the transcriptome as described (Dunn et al., 2013; Ingolia et al., 2009), retaining both
uniquely mapped and multi-mapped reads.
d TIS identification
For TIS analysis on neuron-glia culture RF data, we focused on the 50 -UTR region and proximal 300bp of the CDS and excluded the
downstream region where ribosome runoff after HHT treatment was not complete. In order to calculate TIS score, we used riboSeqR
package and identified ribosomal P sites, which are known to exist at the 12th, 13th or 14th nts of the footprints of lengths 28-29, 30-31,
and 32-33 nts, respectively (Ingolia et al., 2009; Lee et al., 2012). To redress small possible errors in the P site estimation, the P site
counts were smoothed by taking an average of the total counts in a 3 nt window, one nt on each side of the initially identified P site. TIS
score at every nt position on a transcript was calculated as:
D = RHHT --RCHX
Where RHHT = XHHT / NHHT * 10 and RCHX = XCHX / NCHX * 10. X is the smoothed P site count at a position, and N is the total counts in the
50 UTR and the proximal 300 nt region of the transcript.
The following procedure was used to call TISs
(1) 10 candidate peaks were found in each transcript. The first peak was picked based on highest TIS scores. On each side of this
peak, the locations were masked when finding the next peaks if: the location is less than k-bp (k = 9) away from the current
peak; or TIS scores keep decreasing from the current peak. The next peaks are selected the same way in the unmasked region
of the transcript.
(2) Assuming that there is at least one TIS per transcript, the first peak is always called a TIS.
P
(3) If m (m < 10) of the 10 candidate peaks were already called as TISs, for the next peak, a score Sm + 1 = Dm + 1 = m
i = 1 Di is calcuated, where Di is the TIS score at the i-th peak. If Sm + 1 > 0:08, this peak is also called as a TIS. Otherwise, only the previous m
TISs are called for this transcript. This step assures we are only focusing on TISs capturing at least 8% of initiating ribosomes.
Using this algorithm, TISs were called based on the total P site counts in KCl treated and untreated samples. TISs for a transcript in
the two samples were considered the same if they were % 3bp away from each other. For each TIS, the P site count rate was calculated as the P site count over the total counts over all TIS positions. A TIS was excluded if the average rate in KCl+ and KCl- samples
was < 0.08. Although we started off with 10 candidate peaks, not all of them could be reliably detected across samples; therefore, at
this step we kept only the top five that were reliably detectable across most samples. If more than 5 TISs were called for a transcript,
only the top 5 TISs with the highest total P site count rates across KCL+ and KCL- samples were kept. If a NUG codon lay within 3bp
from the called TIS, the TIS was considered overlapping and hence relocated to the position of that NUG codon.
With above criteria, only transcripts with high P site counts at TIS locations can be used to get reliable TIS calls across samples.
Requiring the peak P site counts of R 32 in the considered region of a transcript in the HHT treated group for both KCl+ and KCl-, a
total of 426 transcripts were kept for TIS evaluations.
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Readthrough identification
In order to count reads aligning to non-overlapping regions for readthrough analysis in culture and TRAP-RF data, we used the
BEDTools intersect command (Quinlan and Hall, 2010). Then, similar to prior work (Dunn et al., 2013), we removed reads aligning
to the following positions: 12 nts after the start codon; 15 nts before and 9 nts after the first stop codon, and 15 nts after the second
stop codon. This resulted in four remaining transcriptomic regions: 50 UTR, CDS, readthrough region, and distal 30 UTR. Reads were
counted in each of these regions using the uniq Unix utility.
Readthrough analysis was performed in R. Transcripts were filtered based on CDS counts as follows: in culture RF, transcripts with
R 320 CDS counts across all samples were retained, and in TRAP RF, transcripts with R 128 CDS counts across replicates in either
the Aldh1l1 or Snap25 samples were retained. Subsequently, to avoid false positive identification of readthrough events because of
alternative splicing, if a gene was annotated as having multiple isoforms with stop codons at different genomic locations, only the
transcript with the downstream-most stop codon was retained.
Using edgeR (Robinson et al., 2010), counts were normalized to RPKM, and readthrough rate was defined for each transcript as the
ratio of readthrough region RPKM to CDS RPKM. Next, transcripts with R 32 readthrough region counts across samples were retained. In both culture RF and TRAP-RF datasets, surviving transcripts with R 1% readthrough rate in at least 2 samples were retained for readthrough analysis. Genes with R 100% readthrough or with RPKM (distal 30 UTR) R RPKM (readthrough region), for
any transcript isoform or in any sample, were labeled false positives and eliminated.
d Identification of cell type-specific transcripts in TRAP-RF data
For quality assessment and filtering of TRAP-RF data, CDS counts were normalized to CPM using the edgeR package. Due to the
expression of some glial transcripts in neuronal samples and vice versa, transcripts were classified as either detectable with high
confidence in neurons or astrocytes or as nonspecific background, consistent with prior work (Dougherty et al., 2010). Transcripts
were classified as neuron-detectable by first calculating the average log2-fold-change (logFC) in expression between Aldh1l1 and
Snap25 samples for genes identified as neuronal markers (Dougherty et al., 2012). Among those transcripts surviving initial CDS
count filtering, transcripts with logFC greater than this average plus two standard deviations were identified as detectible in neurons
with 96% confidence. Astrocyte-detectable transcripts were identified analogously. Remaining transcripts were designated non celltype specific.
d

Proteomics
Sample preparation
Neuronal MS data were obtained similar to the method of Prabakaran et al., 2014 (Prabakaran et al., 2014). In short, E16.5 cortical
neurons were cultured for 7 days (3 biological replicates) and depolarized with 55 mM potassium chloride (KCl) for 0, 15, 30, 60, 90,
120 m. For each time point, proteins were extracted in Qproteome mammalian cell lysis buffer (Complete mini and PhosphoSTOP
tablets added (Roche)) using a probe sonicator (15sec, 2x). Protein extracts were reduced with 50 mM dithiothreitol (20 min,
56 C), alkylated with iodoacetamide (30 min, RT), diluted with 8M urea in 50mM triethyl ammonium bicarbonate (TEAB) and digested
using filter aided sample preparation (FASP Protein Digestion Kit, Expedeon). Digestion was performed overnight 37 C with 2 ng/ml
trypsin (Sequencing Grade Modified Trypsin, Promega) in 50 mM TEAB and peptides were subsequently labeled on-filter using
isobaric tags (TMT6plex, Thermo Fisher) according to the manufacturer’s instructions. Labeling was quenched using 5% hydroxylamine and peptides were eluted from the filters using 500 mM NaCl and acidified with 2% formic acid. 10 uL of each peptide eluate
were pooled, desalted using C18 silica tips (Nestgroup) to assess labeling efficiency and to adjust sample amounts to ensure 1:1 total
protein ratios across channels prior to analysis of the remaining samples. Labeled samples were mixed 1:1 and samples were desalted using Oasis HLB columns (Waters). One half of the sample volume was fractionated using high-pH HPLC fractionation on
an Xbridge C18 (3.5mm) 10cm column (Waters) into 55 fractions, the other half by isoelectric focusing on off-gel pH 3-10 Immobiline
Dry Strips (GE Healthcare) into 24 fractions. HPLC fractions were combined based on peptide chromatogram intensities into 22 fractions, whereas isoelectric focusing fractions were desalted using C18 silica tips (Nestgroup). Post vacuum drying, fractions were reconstituted in sample buffer (5% formic acid, 5% acetonitrile) for MS analysis.
d MS analysis
Samples were analyzed on a QExactive mass spectrometer (Thermo) coupled to a micro-autosampler AS2 and a nanoflow HPLC
pump (Eksigent). Peptides were separated using an in-house packed C18 analytical column (Magic C18 particles, 3 mm, 200 Å,
Michrom Bioresource) on a linear 120 min gradient starting from 95% buffer A (0.1% (v/v) formic acid in HPLC-H2O) and 5% buffer
B (0.2% (v/v) formic acid in acetonitrile) to 35% buffer B. A full mass spectrum with resolution of 70,000 (at mass-to-charge of 200)
was acquired in a mass range of 300-1500 mass-to-charge (AGC target 3 3 106, maximum injection time 20 ms). The 10 most intense
ions were selected for fragmentation via higher-energy c-trap dissociation (HCD, resolution 17,500, AGC target 2 3 105, maximum
injection time 250 ms, isolation window 1.6 mass-to-charge, normalized collision energy 27%).
Raw data were analyzed by MaxQuant software version 1.5.2.10 and peptide lists were searched against the mouse Uniprot protein sequence database (February 2016, reviewed entries appended with common laboratory contaminants [cRAP database, 247
entries]) appended with the alternative translational products using the Andromeda search engine. The following settings were
applied: trypsin (specificity set as C-terminal to arginine and lysine) with up to two missed cleavages, mass tolerances set to 20
ppm for the first search and 4.5 ppm for the second search. Methionine oxidation and N-terminal acetylation were chosen as dynamic
modifications and carbamidomethylation of cysteine and TMT labeling of peptide N-termini and lysine residues were set as static
d
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modifications. The minimum peptide length was set to seven amino acids. False discovery rates (FDR) were set to 1% on peptide and
protein levels as determined by reverse database search. Peptide identification was performed with an allowed initial precursor mass
deviation up to 7 ppm and an allowed fragment mass deviation of 20 ppm. For all other search parameters, the default settings were
used.
In Silico Analysis of TISs and readthrough
d Conservation analysis of uTISs and dTISs and readthrough regions
For computing conservation scores of uTIS per transcript, phastCons format files were downloaded from UCSC Table Browser,
querying the coordinates of uTIS codon from the table of phastCons60way. Next, the average score of the three nucleotides was
calculated to define the codon conservation score. Each non-uTIS NTGs in the 50 UTR was annotated using a sliding window
approach, and then the codon conservation score was extracted using a similar strategy as for uTISs. These codons were further
classified into in-frame and out-of-frame based on their location relative to translation start site. To compare uTIS codon score
with average score of 50 UTR, average score of the entire 50 UTR given transcripts with uTIS was calculated. dTISs were analyzed similarly, except that the corresponding CDSs were considered in place of the 50 UTRs.
For the readthrough region, phastCons format files were downloaded using stop codon coordinates, and the average of the conservation scores of the nucleotides in the region was calculated.
d Three nucleotide periodicity
Three-nucleotide periodicity was plotted using the riboWaltz R package as described (Lauria et al., 2018).
d Kozak score computation
A Kozak score of each TIS was computed by comparison to a position weight matrix derived from an empirical assay of ribosome
recruitment on synthetic sequences (Sample et al., 2018). Briefly, from a pool of 300,000 randomized 50 UTRs driving a reporter
expression, the repressive strength of all out-of-frame uTISs was calculated considering all permutations of NNNAUGNN (except
when NNN is AUG). Using the 20 most repressive sequences (i.e., competent to recruit ribosomes), a position weight matrix was
created, based on which the scores for Kozak sequences in natural 50 UTRs studied here were calculated using ‘‘log2probratio’’ function in Biostrings package.
d Motif analysis
Analysis of motif enrichment in the readthrough region was done using CISBP-RNA mouse specific database as described (McLeay
and Bailey, 2010). As controls, 1080 shuffled sequences derived from the readthrough region or 46 readthrough-negative transcripts
were used. Readthrough-negative transcripts were selected to be have robust brain expression and comparable lengths between the
first and second stop codons. Position weight matrices were created using WebLogo (Crooks et al., 2004).
d Free energy computation
Minimum free energies of 48 readthrough transcripts and the 46 readthrough-negative transcripts with comparable lengths between
the first and second stop codons were calculated using ViennaRNA Package 2.0 as described (Lorenz et al., 2011).
d Codon bias analysis
Sequences of interest were selected using BioMart in R, and relative synonymous codon usage (RSCU) (Sharp et al., 1986) was
calculated using the seqinr package for candidate sequences. For readthrough fragments, a codon bias was calculated for each
amino acid as RSCU of the most preferred codon – RSCU of the least preferred codon, and a paired t test was used to compare
this bias calculated from the readthrough positive fragments and a matched set of readthrough negative fragments (defined as
above). For dTIS compared to aTIS, we analyzed codon frequency for 36 nucleotides, starting from the ATG for all sequences
and analyzing only the dTIS with highest confidence for coding potential (in frame, starting with NUG). We tested for alteration of
codon usage using a Chi-test, with Benjamin Hochberg multiple testing correction.
Dual-luciferase assay
Aqp4 test cassette (the last 15 nts of the CDS + 1st stop + 84 nts before the 2nd stop), a negative control (extra stop added after the 1st
stop) or a positive control (1st stop mutated to a sense codon) was cloned between the Renilla and Firefly luciferases of pdLUC, a
dual-luciferase vector that expresses Renilla luciferase constitutively but Firefly luciferase only if the cloned construct is read by ribosomes (Fixsen and Howard, 2010). The test and control plasmids were transfected into DBT glioblastoma cell cultures. After 48 hr,
the two luciferase activities were quantified using the Dual-Luciferase Assay System and GloMax Luminometer with dual injectors
(Promega) following manufacturer’s instructions. Readthrough rate was calculated as described (Grentzmann et al., 1998) and as
follows:
ðFirefly activity=Renilla activityÞtest
X100
ðFirefly activity=Renilla activityÞ + Ct
Immunofluorescence staining
Brain sections, except for those from mice with MCA occlusion, were collected and processed as follows. Adult mice were
euthanized and perfused transcardially with 15 mL ice-cold PBS and then 20 mL 4% ice-cold paraformaldehyde in PBS. Brains
were harvested, fixed in 4% ice-cold paraformaldehyde overnight, and cryoprotected with 10%, 20%, and 30% ice-cold sucrose
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in PBS for 4 h, 4 h, and overnight, respectively. Brains were then frozen in OCT (Sakura Inc), sectioned at 40 mm, and stored at 4 C in
PBS+0.01%NaN3 until staining. For staining, floating brain sections were blocked with 5% normal donkey serum plus 0.3% Triton
X-100 in PBS at room temperature for 1 h, incubated with primary antibody in block at 4 C overnight, washed three times with PBS,
incubated with Alexa fluorophore-conjugated secondary antibodies (1:500, Invitrogen) in block at room temperature for 1 h, washed
two times with PBS, incubated with 300nM DAPI (Sigma) at room temperature for 5 m, washed two times with PBS, and mounted for
confocal imaging (Perkin Elmer).
Brain sections from mice with MCA occlusion were prepared as follows. After transcardial perfusion and overnight fixation as
above, the brains were sliced at 1.5 mm, washed with cold PBS for 1 hr and then dehydrated in a series of ethanol concentrations
(50%, 70%, 80%, 95%, 100%, 100%, and 100%, each for 1.5 h). After clearing twice with xylene and vacuum-infiltering twice with
58 C paraffin, each time for 1 hr, slices were aligned in molds containing 580C paraffin and embedded in the same paraffin letting the
paraffin cool down. Sections were made at 7 um, collected on charged slides, and dried overnight. For staining, slides were first rehydrated by treating in Xylene (3 X 5 m), 100% ethanol (2 X 10 m), 95% ethanol (1 X 5 m), 80% (1 X 5 m), 70% (1 X 5 m), 50% (1 X 5 m)
and distilled water (2 X 5 m). Antigen unmasking was then performed by dipping the slides in 99 C 10 mM sodim citrate buffer and
letting the buffer cool down on bench top for 30 m. Slides were then washed 2 X 5 m with PBST, and then blocked and stained as
described for floating sections above.
Staining of coverslip cultures were done as described previously (Dalal et al., 2017). Processing and staining of the retinas and
kidneys were done as described for floating brain sections above, except that 14 um-thick sections were collected on charged slides.
Primary antibodies and dilutions were: mouse anti-V5 (Sigma, V8012, 1:1000), mouse anti-GFAP (Biogenex, MU020-UC, 1:1000),
rabbit anti-cMyc (Sigma, C3956, 1:100), mouse anti-cMyc (Santa Cruz, 9E10, 1:100), goat anti-AQP4 (Santa Cruz, SC-9888, 1:100),
rat anti-PECAM-1 (BD Pharmigen, 550274, 1:50), and rabbit anti-AQP4X (made in collaboration with Cell Signaling Technology,
60789, 1:1000). The anti-AQP4X was a polyclonal antibody generated by immunizing rabbits with a synthetic peptide corresponding
to residues surrounding Asp333 of mouse AQPX and purifying the antibody with protein A and peptide affinity chromatography.
Western blot
Mice were euthanized, and their brains were rapidly homogenized on ice in RIPA buffer (50 mM pH 8.0 Tris-HCl, 150 mM NaCl, 1%
NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1mM NaVO4, 1mM NaF, Roche complete protease inhibitor tablet). Lysates were
cleared by centrifuging at 16,000 xg at 4 C for 10 m. Protein concentration was measured using a BCA kit (ThermoScientific). An
aliquot of 30 mg of protein was boiled for 5 min in an equal volume of 2x Laemmli buffer (BioRad) and electrophoresed in Mini-Protean
Precast gels (BioRad) for 1h at 120 V. Proteins were transferred to a polyvinyl membrane using Semi-Dry Transfer Cell (BioRad) for
30 min at 10 V and following manufacturer’s instructions. The blot was then blocked in 5% non-fat dried milk in tris-buffered saline
with 0.1% Tween-20 (TBST) for 1 h at room temperature, incubated with anti-AQP4X in block (1:2000, Cell Signaling Technology)
overnight at 4 C, washed three times with TBST, incubated with HRP-conjugated secondary antibody in block (1:5000, BioRad)
for 1 h at room temperature, washed three times with TBST, and finally developed using Signal-Fire ECL reagent (Cell Signaling Technology) and My ECL imager (ThermoScientific).
Transfection
DBT glioblastoma cell line was grown in 6 well plates in DMEM with 10 fetal bovine serum (Sigma) and 1x penicillin and streptomycin.
At 60% confluency, the cells were transfected with 1.5 mg of plasmids using Lipofectamine 2000 (Invitrogen) and following manufacturer’s instructions. Medium was changed 24 h post-transfection, and immunofluorescence staining was done 48 h posttransfection.
AAV preparation and intracranial injection
A cMyc tag was cloned at the 50 ends of the Aqp4 cDNA containing an extra stop codon beyond the first stop codon (cMycAqp4X-),
Aqp4 cDNA with the first stop codon mutated to a sense codon (TGA to TGG, cMycAqp4X+), and CFP cDNA. Modified cDNAs were
then cloned into pAAV-GFAP-EGFP after removing the EGFP with AgeI and HindIII. The plasmids were packaged into AAV9 by the
Hope Center Viral Vector Core at Washington University. Two uL of the viruses were intracranially injected into P1 (AAV9-Gfap::cMycAqp4X- and AAV9-Gfap::cMyc-Aqp4X+) or P90 (for AAV9-Gfap::cMyc-CFP) mice. After 3 weeks, the mice were processed for
floating brain section immunofluorescence.
tMCAO
tMCAO was performed as described previously (Miller et al., 2001). Briefly, 14 week-old C57BL/6 mice were anesthetized with isoflurane, and the left common carotid artery (CCA) was exposed through a midline cervical incision. A 6.0-gauge nylon suture coated
with silicone was inserted in the CCA lumen and advanced through the internal carotid artery to the origin of the MCA. Interruption of
the blood flow in the MCA territory was confirmed with laser Doppler. After 60 m, the suture was withdrawn, and the reperfusion of the
MCA territory was confirmed by inspection with an operating microscope and more distally by laser Doppler. After the procedure,
animals recovered in an incubator before returning to home cages. The brains were harvested after 24 h and processed for
immunofluorescence staining as mentioned above.
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QUANTIFICATION AND STATISTICAL ANALYSIS
P site counts (Figures 1E, 2A, 2B, 3, S1, and S6; Table S1), readthrough rate calculations (Tables S3 and S4), Pearson correlation
calculations (Figures 6B, 6C, S2B, S2C, S2E, and S2G) and statistical tests for significance were performed in R. Identification of
cell-type-specific transcripts in the TRAP-RF dataset (Figure 6D) was done with the Specificity Index package (Dougherty et al.,
2010). For uTIS and dTIS conservation analysis (Figures 2C and 2D) and minimum free energy analysis for readthrough candidates
(Figure S6), levels of significance were calculated using Wilcoxon’s rank sum test since the score distributions appeared bimodal. For
quantifying immunofluorescence signals (Figures 5 and S5), three mice per condition and six sections per mouse were analyzed,
and t test was used. KCl depolarization-mediated changes in TIS usage were tested for significance using either Chi-square test
(Figure 3A, across individual transcripts) or paired t test (Figure 3C, pairwise comparisons). Overall difference in Kozak strengths
of the three TISs was tested post hoc using Tukey’s HSD test, whereas pairwise differences were tested using t test (Figure S2A).
Statistical tests and results are also reported in the text, figure panels and figure legends. Difference was deemed significance
when p < 0.05.
DATA AND SOFTWARE AVAILABILITY
Raw and analyzed sequencing data are available at GEO GSE77076 (Cell culture RF without HHT and with or without KCl),
GSE115483 (in vivo TRAP-RF) and our lab URL http://genetics.wustl.edu/Dougherty_Data/SapkotaEtAl_2018_upload_jdlab/ (Cell
culture RF with HHT and with or without KCl).
Scripts used for sequencing data processing as well as R codes used for downstream analyses are available upon request.
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Cell-Type-Speciﬁc Proﬁling of Alternative
Translation Identiﬁes Regulated Protein
Isoform Variation in the Mouse Brain
Darshan Sapkota, Allison M. Lake, Wei Yang, Chengran Yang, Hendrik Wesseling, Amanda
Guise, Ceren Uncu, Jasbir S. Dalal, Andrew W. Kraft, Jin-Moo Lee, Mark S. Sands, Judith
A. Steen, and Joseph D. Dougherty

Figure S1. Neuron/glia culture ribosome footprints indicate bona fide translation. Related to Figure
1. A) More than 60% of P-sites detected in the footprints mapping to the CDS shows the translation of the
correct reading frame. B) P-sites detected in the footprints mapping to the CDS exhibit 3-nucleotide
periodicity of ribosomes. Data are from a ‘no HHT, No KCl’ sample, and the same pattern was observed
with other samples.

Figure S2. Identified TISs reveal the complexity of initiation from neural transcripts. Related to
Figure 1. A) Kozak strength varies significantly between TISs. Overall comparison of Kozak strengths was
done using post hoc Tukey’s Honestly Significance Difference test and showed a highly significant
difference (p = 0, not shown in the box). Pair-wise comparison was done using t tests (***: p  0.001; ****:
p  0.0001). B) Comparison of TIS usage and Kozak strength shows that TISs with higher Kozak scores,
especially aTISs, are more favorably used for initiation (C) uTISs with higher Kozak scores inhibit initiation
from aTISs. The Y axis represents the sum of the kozak scores of all uTIS in a given transcripts. (D-E)
Longer 5’UTRs contain more uTISs (D) and inhibit initiation from aTISs more strongly than shorter 5’UTR
(E). (F) Regression-based model prediction shows the Kozak scores of aTIS and uTIS as the strongest
determinants of initiation from aTISs (R-squared 0.519). (G) aTISs with higher Kozak scores moderately
reduce initiation from dTISs. r = Pearson correlation coefficient. TIS usage was calculated as the P-site
counts at a TIS over total P-site counts across all TISs on a given transcript. Kozak Strength was
calculated by comparing the TIS context sequences with a position weight matrix derived from an a
polysome profiling experiment determining ribosome loading on synthetic sequences as described in
Sample et. al., 2019 and shown in arbitrary unit in the Y axis, with 1 indicating the best strength.

Figure S3. Detection of readthrough peptides in mouse brain mass spectrometry data. Related to
Figures 4 and 6. (A) Peptides corresponding to three readthrough regions are shown. Stop codonrecoded amino acids are in red. (B) Tandem mass spectra and mass-to-charge ratios (m/z) of b and y
product ions corresponding to the Aqp4 readthrough peptide is shown. Mouse brain mass spectrometry
data reported by Sharma et al 2015 were examined setting the posterior error probability cut off value at
0.01.

Figure S4. Validation of anti-Aqp4X antibody. Related to Figures 5 and S5. DBT glioblastoma cells
were transfected with constructs expressing normal Aqp4 with an N-terminal cMyc tag (A) or Aqp4X with
a C-terminal V5 tag (B). Immunostaining of the transfected cells shows that a cMyc-positive cell does not
express Aqp4X, whereas a V5-positive cell does. Scale bars = 20 μM.

Figure S5. Readthrough confers the perivascular localization ability to AQP4 in the central
nervous system. Related to Figure 5. A) Western blot on brain lysates detects the expected 35 kD band
in the adult brain but not in the developing brain. Note that high molecular weight smear accompanied the
expected band, as is commonly seen for other AQP4 antibodies89. B) Immunostaining of the adult
mouse brain shows diffused expression of AQP4 and PECAM 1-overlapping perivascular expression of
AQP4X in different regions. C) Quantification of MFIs from B shows the signal from anti-AQP4X is
significantly more perivascular than the total (AQP4 + AQP4X) signal from anti-AQP4. D) AAV9-mediated
astrocytic expression of cMyc-tagged AQP4X- (an extra stop codon added to prevent readthrough) or
AQP4X+ (stop mutated to allow constitutive readthrough) in the brain followed by immunostaining shows
that cMycAQP4 is less contiguous with the perivascular PECAM-1 than cMycAQP4X. Regions of interest
were drawn around PECAM-1 to distinguish perivascular cMyc. E) Quantification of cMyc MFIs from D
shows that perivascular cMyc accounts for 4% and 14% of the total cMyc in AAV9-Gfap::cMycAqp4Xinjected brain and AAV9-Gfap::cMycAqp4X+ injected brain, respectively. F, G) Immunofluorescence
staining of the retina (F) and kidney (G) from adult mice shows the expression of AQP4X in these tissues.
Note that AQP4X largely perivascular in the retina but completely overlaps with AQP4 in the kidney. The
nuclear stain DAPI is removed from the single channel images for the retina to highlight the presence of
AQP4 outside the perivascular region (arrow). For C and E: 3 mice; 6 sections/mouse. Unpaired t-test;
error bars, standard errors of mean. MFI, mean fluorescence intensity; AAV9, Adeno-associated virus 9.
Scale bars = 20 μM in B, 50 μM in D, G and G.

Figure S6. Readthrough candidates show 3-nucleotide periodicity in the CDS and specific
sequence features in the readthrough region. Related to Figure 6. A, B) P sites detected globally in
Snap25::Rpl10a-Egfp TRAP-RF and Aldh1l1::Rpl10a-Egfp TRAP-RF are plotted in A and B, respectively.
C) Position weight matrix reveals TGA as the commonest stop codon in transcripts undergoing
readthrough. Inset shows the magnification of the 20-nucleotide readthrough window. D, E) Analysis of
motif enrichment for readthrough candidates using shuffled sequences as controls (D) and readthroughnegative candidates as controls (E) shows the overrepresented motifs for specific RNA-binding proteins.
F) Conservation analysis of sequence between the first and second stop codons suggests that
readthrough positive regions tend to be conserved, but not significantly, as compared to readthrough
negative regions. Fisher’s exact test was performed on the odds ratios of positive and negative groups.
PhastCons scores greater than 0.5 are considered to represent conservation arbitrarily. G) Wilcoxon test
to compare minimum free energies reveals a more stable secondary structure (less free energy) between
the first and second stop codons of readthrough candidates. 48 in vivo readthrough candidates were used

in all analyses (2 were removed due to transcript ID problem). 46 readthrough-negative transcripts with
matched lengths between the first and second stop codons were used in E, F and G. In C, D and E, Y
axis represents conservation in bits.

Table S2. Peptide products of alternative translation initiation sites detected in the mouse brain
mass spectrometry data from Sharma et al, 2015. Related to Figure 2 and Table 1. “+” and “-” indicate
downstream and upstream relative to the canonical initiation site, respectively.
SN
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.

Transcript ID
ENSMUST00000020657
ENSMUST00000067664
ENSMUST00000021933
ENSMUST00000030134
ENSMUST00000021674
ENSMUST00000100802
ENSMUST00000067664
ENSMUST00000110082
ENSMUST00000103008
ENSMUST00000027377
ENSMUST00000111230
ENSMUST00000031131
ENSMUST00000106255
ENSMUST00000031565
ENSMUST00000112172
ENSMUST00000112229
ENSMUST00000110082
ENSMUST00000108857

Gene name
Ube2b
Ywhae
Ctsl
Rad23b
Fos
Nufip2
Ywhae
Calm1
Sdcbp
Igfbp5
Tagln2
Uchl1
Cap1
Fscn1
Tmsb4x
Gpm6b
Calm1
Atox1

Alternative initiation site
-24
-66
-27
-277
-46
-45
-49
-100
-54
-405
7
15
9
12
7
12
12
6

Frame
In frame
In frame
In frame
Out of frame
Out of frame
In frame
Out of frame
Out of frame
In frame
In frame
Out of frame
In frame
In frame
In frame
Out of frame
In frame
In frame
In frame

Table S3. Transcripts showing at least 1% readthrough identified in vitro. Related to Figure 4.
SN
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.

Transcript symbol
2010107E04Rik
Aqp4
Brk1
Ctxn1
Dlx1
Dynll2
Gpm6a
Mdh1
Mlc1
Mt1
Mt2
Ncan
Pea15a
Pfn2
Plat
Ptms
Ssna1
Tmem261

Readthrough rate
0.033
0.382
0.048
0.327
0.185
0.106
0.056
0.154
0.055
0.024
0.041
0.014
0.015
0.015
0.102
0.027
0.322
0.230

Table S4: Transcripts with at least 1% readthrough in vivo. Related to Figure 6. Readthrough rates are an
average of two Snap25::Rpl10a-Egfp and two Aldh1l1::Rpl10a-Egfp samples for neuron- and astrocyte-enriched transcripts,
respectively, and an average of all four for cell type-nonspecific transcripts.

Neuronal

Astrocytic

Non cell type-specific

Transcript

Readthrough rate

Transcript Readthrough rate

Transcript

Readthrough rate

Atp1a3

0.017

Aldoc

0.065

2010107E04Rik

0.051

Celf5

0.24

Aqp4

0.189

Arl3

0.026

Clstn3

0.041

Atp1a2

0.025

Brk1

0.023

Cox6a1

0.023

Clu

0.014

Camk2n1

0.035

Ctxn1

0.18

Csrp1

0.014

Fam195b

0.08

Dynll2

0.02

Cst3

0.019

Lmtk3

0.319

Eef1a2

0.024

Fam19a5

0.15

Ssna1

0.294

Fam163b

0.182

Manbal

0.078

Triap1

0.17

Fxyd7

0.015

Fopnl

0.445

Tmem88b

0.33

Hint1

0.064

Map4

0.317

Ubl3

0.095

Lynx1

0.035

Mbp

0.012

Map1lc3a

0.025

Mlc1

0.139

Mdh1

0.071

Mt1

0.098

Pld3

0.014

Mt2

0.037

Prr24

0.209

Ndrg2

0.024

Ptms

0.023

Pea15a

0.023

Serp2

0.179

Sparc

0.009

Thy1

0.014

Smim7

0.119

Tmem240

0.041

Ttr

0.033

Tmem261

0.209

Yaf2

0.243

